Concept information
Preferred term
Insulin Glargine
Type
-
mesh:Descriptor
Definition
- A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.
Broader concept
Entry terms
- 160337-95-1
- 2ZM8CX04RZ
- A21-Gly-B31-Arg-B32-Arg-insulin
- Glargine
- Insulin, Gly(A21)-Arg(B31,B32)
- Insulin, Glycyl(A21)-Arginyl(B31,B32)
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- analogs & derivatives (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
160337-95-1
-
2ZM8CX04RZ
-
A21-Gly-B31-Arg-B32-Arg-insuline
-
Glargine
-
Gly(A21)-Arg(B31)-Arg(B32)-insuline
URI
http://data.loterre.fr/ark:/67375/JVR-PMXTT6NW-B
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}